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Abstract
Introduction: This study provides a comprehensive summary of the sociodemographic,
psychosocial and health characteristics of a large population-based cohort of Ontario
home care clients (aged 50 years and over) with dementia and examines the variation in
these characteristics in those with co-existing neurological conditions.
Methods: Clients were assessed with the Resident Assessment Instrument-Home Care
(RAI-HC) between January 2003 and December 2010. Descriptive analyses examined the
distribution of these characteristics among clients with dementia relative to several
comparison groups, as well as clients with other recorded neurological conditions.
Results: Approximately 22% of clients (n = 104 802) had a diagnosis of dementia (average
age 83 years, 64% female) and about one in four within this group had a co-existing
neurological condition (most commonly stroke or Parkinson disease). About 43% of those
with dementia did not live with their primary caregiver. Relative to several comparison
groups, clients with dementia showed considerably higher levels of cognitive and functional
impairment, aggression, anxiety, wandering, hallucinations/delusions, caregiver distress
and a greater risk for institutionalization. Conversely, they showed a lower prevalence of
several chronic conditions and lower levels of recent health service use. Depressive
symptoms were relatively common in the dementia and other neurological groups.
Conclusion: Clients with co-existing neurological conditions exhibited unique clinical
profiles illustrating the need for tailored and flexible home care services and enhanced
caregiver assistance programs.
Keywords: dementia, Alzheimer disease, neurological disorders, mental health, home
care
Introduction
Current global estimates suggest that
approximately 35.6 million people have a
form of dementia, including Alzheimer
disease.1 Within Canada, approximately
half a million people have dementia with
prevalence estimates increasing exponen-
tially beyond the age of 65 years.2 Aside
from its personal cost, the ongoing care of
those with dementia poses a significant
societal and economic burden both in
terms of care provided by family as well
as formal care services and costs.3-6
Although relatively few seniors will
require costly institutional care as they
age,7 the risk increases significantly for
older adults with dementia.8 The provi-
sion of timely, appropriate and co-ordi-
nated home care services to older
Canadians with dementia may help miti-
gate institutional risk and costs while
supporting seniors’ preferences to remain
at home surrounded by familiar settings
and social networks for a longer period of
time.9
Of the estimated 1 million Canadians
receiving home care services at any given
time,10 over three-quarters (82%) are 65
years or older,11 and about 20% have
Alzheimer disease or other dementias.12
Comprehensive understanding of the
social, mental and physical health needs
of older Canadians with dementia receiv-
ing community-based care is required to
ensure responsive care planning and the
optimal management of this growing and
vulnerable population. A thorough exam-
ination of client characteristics and care
needs may further facilitate the identifica-
tion of supportive strategies for over-
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whelmed family caregivers.13 Previous
studies have primarily examined the care
needs and service use of older adults with
dementia living in residential or long-term
care facilities in the United States.14-16
Recent population-based studies of com-
munity-dwelling seniors with dementia
across Canada are scarce. Earlier work
(largely derived from the 1991–2001
Canadian Study of Health and Aging17,18)
may not reflect changes in the complexity
of care or service needs facing people with
dementia and their caregivers. There is
also a paucity of research characterizing
those who have dementia along with a
comorbid neurological illness. This is an
important sub-population given the prob-
able rise in caregiver stress and health
service use due to the increasing severity
of symptoms related to co-occurring neur-
ological conditions.19,20
To address current knowledge and policy
gaps relevant to the quality of life and
care of older Canadians with dementia, our
objectives were to (1) provide a compre-
hensive summary of the sociodemographic,
psychosocial and health characteristics of a
large population-based cohort of home care
clients with dementia relative to several
comparison groups; and (2) explore the
variation in these characteristics in clients
with dementia alone compared with those
with co-existing neurological conditions




This cross-sectional study is part of a
larger research program (Innovations in
Data, Evidence, and Applications for
Persons with Neurological Conditions, or
ideas PNC)21 designed to provide preva-
lence estimates and clinical profiles of
people with one or more of 10 priority
neurological conditions receiving continu-
ing care services.
Our sample included all home care clients
in Ontario aged 50 years or older assessed
with the Resident Assessment Instrument-
Home Care (RAI-HC) between January
2003 and December 2010. The RAI-HC
provides a standardized comprehensive
assessment of a client’s sociodemographic
characteristics, physical and cognitive
status, health conditions and selected
diagnoses, behavioural problems, medica-
tion use and receipt of specific services.
Since 2002, the RAI-HC has been man-
dated for all long-stay (i.e. expected to
receive services for more than 60 days)
home care clients with assessment data
captured in the Ontario Association of
Community Care Access Centres (OACCAC)
database.
We first excluded RAI-HC assessments
completed in an inpatient acute care
setting for the purpose of placement
(7.6% of all assessments) and then
selected the most recent assessment avail-
able for clients (n = 520 479). This
sample was reduced to 488 374 following
our age restriction (50–115 years). We
excluded those assessed prior to 2003
(0.02%) due to concerns about data
completeness during this initial implemen-
tation phase. The final analytical sample
included 488 290 unique clients.
The University of Waterloo houses de-
identified copies of OACCAC data as part
of a license agreement between interRAI
and the Canadian Institute for Health
Information.22 These holdings are gov-
erned by regulations to protect personal
privacy but do not require individual
client consent (beyond that already
obtained by contributing organizations
during assessment).
Our study received research ethics approval
from the University of Waterloo’s Office of
Research Ethics (project #17045).
Measures
Trained case managers, usually nurses or
social workers, perform routine RAI-HC
assessments using the best available
information (e.g. clinical judgement; case
discussions with attending physicians,
other formal care providers and family
members; health record review). The
reliability and validity of the instrument
has been established across a range of
populations and settings.23-26
We examined the following RAI-HC items:
clients’ sociodemographic status (age, sex,
marital status, whether trade-offs in pur-
chasing needed treatment were made due
to limited funds); psychosocial character-
istics (availability of a caregiver, living
arrangements, presence of caregiver dis-
tress); health status (cognitive and func-
tional impairment, health instability,
depressive and other neuropsychiatric
symptoms, behavioural problems, select
disease diagnoses); recent hospitalization
and emergency department visits; and
medication use in the previous week (i.e.
9+ medications, 1+ medications from
selected classes [antipsychotic, anxiolytic,
antidepressant, hypnotic, cholinesterase
inhibitor and/or memantine use]). Details
regarding all medications used in the
previous week are manually recorded from
containers, verified with clients/caregivers
and transcribed electronically.
We examined five validated scales derived
from RAI-HC items: Cognitive Perfor-
mance Scale (CPS) (range 0–6);27 Activities
of Daily Living (ADL) Self-Performance
Hierarchy Scale (range 0–6);24,28 Changes
in Health, End-stage Disease and Signs and
Symptoms (CHESS) Scale (range 0–5);29,30
Method for Assigning Priority Levels
(MAPLe) (range 1–5);31 and Depression
Rating Scale (DRS) (range 0–14).32,33
We also examined a modified Aggressive
Behaviour Scale (ABS)34 derived from the
sum of any occurrence of four behaviours
(verbal abuse, physical abuse, socially
inappropriate behaviour or resisting care)
in the previous three days, and a summary
measure of impairment in four instrumental
ADLs (some or greater difficulty with meal
preparation, managing finances, managing
medications and transportation). Higher
scores on all these scales indicate more
severe impairment.
The CPS reflects level of cognitive impair-
ment and has been validated against
the Mini-Mental State Examination.35 It
includes four items (short-term memory,
cognitive skills for daily decision making,
expressive communication and eating self-
performance) and ranges from 0 (intact)
to 6 (very severe impairment).27,35 The
CHESS scale ranges from 0 (stable) to 5
(unstable health) and combines symptoms
(vomiting, dehydration, decline in food/
fluid intake, weight loss, shortness of
breath, edema) with items capturing
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recent decline (in cognition and ADL) and
end-stage disease. Higher CHESS scores
predict mortality, institutionalization and
hospitalization in older adults across care
settings.29,36,37 The MAPLe differentiates
clients into five priority levels (low to very
high) based on level of cognitive and ADL
impairment, behavioural issues, environ-
mental concerns and self-reliance. Higher
levels are predictive of institutionalization
and caregiver stress.31
The RAI-HC contains a diagnostic check-
list for commonly occurring conditions
in an older population. Conditions were
considered present if a doctor diagnosed
them, a home care professional was
required to treat or monitor them, or the
disease was a reason for hospitalization in
the previous 90 days. Neurological diag-
noses captured on this checklist include
dementia (Alzheimer disease and/or
other dementias), multiple sclerosis (MS),
Parkinson disease/Parkinsonism (PD),
traumatic brain injury (TBI, referred to
as ‘‘head trauma’’ on the instrument) and
stroke. There are open-ended fields for
free-text entry of diagnoses not on the
checklist. Six neurological conditions were
coded as present/absent based on a
review of all free-text entries: epilepsy/
seizure disorder, Huntington disease
(HD), muscular dystrophy (MD), cerebral
palsy (CP), spinal cord injury (SCI) and
amyotrophic lateral sclerosis (ALS). The
free-text terms were defined by consensus
of an expert review committee including
neurologists, psychiatrists and geriatri-
cians. The conditions listed above (exclud-
ing stroke) are the 10 priority neurological
diagnoses identified by the Public Health
Agency of Canada for the ideas PNC
program. We included stroke in our
analyses because it is a common and
disabling condition in older people.
Data supporting the accuracy of diagnoses
recorded on RAI instruments have been
published elsewhere.37-39 Wodchis et al.38
showed sensitivities of 0.80 or greater for
several common conditions in Ontario
complex continuing care settings (e.g.
stroke, diabetes, cancer, chronic obstruc-
tive pulmonary disease [COPD], heart
failure). Comparable sensitivity estimates
were observed for PD (0.87), Alzheimer
disease (0.85, allowing for a check of
either ‘‘Alzheimer’s’’ and/or ‘‘Dementia
other than Alzheimer’s Disease’’ on the
RAI), CP (0.84) and seizure disorder
(0.75). Sensitivity estimates were low
(< 0.50) for other neurological condi-
tions, including TBI and MS.
Analyses
We conducted descriptive analyses to
examine the distribution of sociodemo-
graphic, psychosocial and health character-
istics by the following comparison groups:
‘‘Dementia,’’ ‘‘Stroke,’’ ‘‘Other Neurolo-
gical Condition’’ (presence of 1+ of the
priority neurological conditions – MS, PD,
TBI, HD, MD, CP, SCI, ALS, epilepsy) and
‘‘Cognitively Intact Controls’’ (clients with-
out any of the selected 11 neurological
conditions and a CPS score of 0 or 1).
Descriptive analyses were also performed
comparing the characteristics of those
with dementia alone to those with demen-
tia and other documented neurological
conditions (i.e. dementia with stroke only,
dementia with PD only, dementia with PD
and stroke only, dementia with TBI only).
These comparison groups excluded clients
with any of the other selected neurological
conditions.
Results
Clients with dementia vs. stroke, other
neurological conditions and cognitively
intact controls (Tables 1A & 1B)
Our analysis included 104 802 clients
(21.5%) with a diagnosis of dementia,
85 579 (17.5%) with stroke and 23 007
(4.7%) with one or more of the other
priority neurological conditions (20 972
(4.3%) clients had a recorded diagnosis of
both dementia and stroke). Almost half
(n = 236 763; 48.5%) were in the cogni-
tively intact control group. Excluded from
the analyses were 59 089 clients (12.1%)
with meaningful cognitive impairment
(CPS 2+) but no priority neurological
diagnosis, and 22 clients with missing
CPS values.
Compared with the stroke and other
neurological groups, clients with dementia
were more likely to be female (63.7%) and
older, with a mean age (standard devia-
tion) of 83.2 (7.6) years. Across all groups,
women were significantly less likely to be
married than were men. Relatively few
clients reported making economic trade-
offs, and this was less common for
dementia clients than for those with other
neurological conditions. Compared with
controls, clients across all three diagnostic
groups were more likely to co-reside with
their primary caregiver. Among those with
dementia or stroke this caregiver was
most often a child or child-in-law. Clients
with dementia were more likely to have
reported conflicts with others, a distressed
caregiver, moderate to severe cognitive
impairment, significant difficulties with
Instrumental Activities of Daily Living
(IADLs), and some impairment in ADLs
(Table 1A).
Dementia clients were more likely to have
some level of health instability and
considerably higher levels of aggression,
wandering, anxiety and hallucinations/
delusions than all other groups (Table 1B).
These findings help to explain the signifi-
cantly greater proportion of dementia clients
with high to very high MAPLe scores
(Figure 1) and distressed caregivers. For
all sub-groups, the proportion of clients
with a distressed caregiver increased with
increasing MAPLe scores (Figure 2).
However, for all levels of MAPLe, the
proportion of clients with a distressed
caregiver was relatively higher for those
with dementia than those in the comparison
groups. Clinically important depressive
symptoms were slightly more common in
dementia clients than the other groups,
though depression and anxiety were not
uncommon in clients with other neurologi-
cal conditions or stroke.
For all groups, the most common
comorbid diagnoses were cardiovascular
diseases, arthritis and diabetes. Most
clinical diagnoses were less prevalent in
clients with dementia or other neurologi-
cal conditions relative to clients in the
stroke or control groups. All three neuro-
logical diagnostic groups showed a
lower prevalence of cancer. A recent fall,
unsteady gait and pressure ulcers were
more common in clients with other
neurological conditions and then in those
with stroke. Relative to cognitively intact
clients, swallowing problems were more
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TABLE 1A
Sociodemographic, psychosocial and functional characteristics among home care clients by diagnostic group, Ontario, Canada, 2003–2010
Percent (95% confidence interval)a
Characteristic Cognitively intactb
(n = 236 763)
Other neurological conditionsc
(n = 23 007)
Stroke
(n = 85 579)
Dementia
(n = 104 802)
Sociodemographic
Mean age (SD), years 77.1 (11.4) 73.3 (11.8) 80.5 (9.5) 83.2 (7.6)
85+ 27.8 (27.6–28.0) 17.2 (16.7–17.7) 35.1 (34.8–35.4) 43.6 (43.3–43.9)
Sex
Female 65.1 (64.9–65.3) 55.3 (54.6–55.9) 57.5 (57.2–57.9) 63.7 (63.4–63.9)
Married
Female 30.1 (29.9–30.3) 37.8 (36.9–38.6) 27.1 (26.7–27.5) 26.9 (26.6–27.2)
Male 59.9 (59.5–60.2) 61.5 (60.6–62.5) 63.9 (63.4–64.4) 65.5 (65.1–66.0)
Widowed
Female 54.3 (54.1–54.6) 39.3 (38.5–40.1) 61.6 (61.2–62.1) 64.1 (63.7–64.5)
Male 21.7 (21.4–22.0) 14.9 (14.2–15.6) 22.0 (21.6–22.5) 24.1 (23.6–24.5)
Made economic trade-offs 1.9 (1.9–2.0) 2.7 (2.5–2.9) 1.8 (1.8–1.9) 1.0 (0.9–1.1)
Psychosocial
Co-resides with primary caregiver
No 46.3 (46.1–46.5) 37.2 (36.5–37.8) 40.7 (40.4–41.1) 42.9 (42.6–43.2)
Yes 50.3 (50.1–50.5) 59.5 (58.9–60.2) 57.6 (57.2–57.9) 56.0 (55.7–56.3)
No such helper 3.4 (3.3–3.5) 3.3 (3.1–3.6) 1.7 (1.6–1.8) 1.1 (1.0–1.1)
Primary caregiver
Child or child-in-law 46.5 (46.3–46.7) 34.0 (33.3–34.6) 49.9 (49.6–50.2) 53.7 (53.4–54.0)
Spouse 32.2 (32.1–32.4) 42.3 (41.7–43.0) 35.3 (35.0–35.6) 33.7 (33.5–34.0)
Other relative 9.9 (9.8–10.0) 12.5 (12.1–13.0) 7.7 (7.6–7.9) 7.6 (7.4–7.7)
Friend/neighbour 7.9 (7.8–8.0) 7.8 (7.5–8.2) 5.4 (5.2–5.5) 3.9 (3.8–4.0)
Conflicts with others 10.1 (10.0–10.2) 12.4 (12.0–12.8) 13.1 (12.9–13.3) 17.2 (17.0–17.5)
Caregiver distressed 10.0 (9.9–10.1) 21.6 (21.1–22.1) 22.6 (22.3–22.9) 34.9 (34.6–35.2)
Functional
CPS score
Intact (0–1) 100.0 63.2 (62.5–63.8) 48.0 (47.7–48.4) 7.4 (7.3–7.6)
Mild impairment (2) — 28.1 (27.5–28.7) 32.7 (32.4–33.0) 44.6 (44.3–44.9)
Moderate impairment (3–4) — 5.8 (5.5–6.1) 12.2 (12.0–12.4) 29.3 (29.0–29.5)
Severe impairment (5–6) — 2.9 (2.7–3.2) 7.1 (6.9–7.3) 18.7 (18.4–18.9)
ADL score
Independent (0) 78.4 (78.2–78.6) 46.9 (46.3–47.5) 50.2 (49.9–50.5) 37.2 (36.9–37.5)
Supervision/limited (1–2) 15.4 (15.2–15.5) 26.9 (26.3–27.4) 28.0 (27.7–28.3) 37.9 (37.6–38.2)
Extensive (3–4) 4.9 (4.9–5.0) 17.9 (17.4–18.4) 15.3 (15.0–15.5) 18.8 (18.5–19.0)
Dependence (5–6) 1.3 (1.2–1.3) 8.3 (8.0–8.7) 6.5 (6.4–6.7) 6.1 (6.0–6.3)
IADL score
d
0 15.2 (15.1–15.3) 4.4 (4.1–4.6) 3.8 (3.7–4.0) 0.7 (0.6–0.7)
1–2 41.1 (40.9–41.3) 23.3 (22.7–23.8) 17.7 (17.5–18.0) 4.4 (4.3–4.5)
3–4 43.7 (43.5–43.9) 72.4 (71.8–72.9) 78.4 (78.1–78.7) 95.0 (94.8–95.1)
Abbreviations: CPS, Cognitive Performance Score; IADL, Instrumental Activity of Daily Living; RAI-HC, Resident Assessment Instrument-Home Care; SD, standard deviation.
a Except where otherwise indicated.
b Clients without any of the 11 selected neurological conditions and CPS of 0 or 1.
c Clients with § 1 of the other selected neurological conditions (excluding dementia and stroke).
d Summary of the following IADLs on the RAI-HC: meal preparation, managing finances, managing medications and transportation; represents # of activities where client experiencing some/
greater difficulty performing on own.
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prevalent in the three neurological diag-
nostic groups, particularly in clients with
dementia.
Dementia clients were less likely than the
other groups to have experienced one or
more ED visits or hospitalizations in the
previous 90 days or to use nine or more
medications. Conversely, they were more
likely than the other groups to be taking
an antipsychotic/neuroleptic. Other psy-
chotropic drug classes were more com-
monly used by clients with other
neurological conditions. Multiple medica-
tion use (9+) was most common in stroke
clients, presumably due to their relatively
higher levels of comorbid illnesses (e.g.
diabetes, cardiovascular diseases [CVDs]).
TABLE 1B
Health characteristics among home care clients by diagnostic group, Ontario, Canada, 2003–2010
Characteristic Percent (95% confidence interval)a
Cognitively intactb
(n = 236 763)
Other neurological conditionsc
(n = 23 007)
Stroke
(n = 85 579)
Dementia
(n = 104 802)
Health Instability (CHESS)
None (0) 32.0 (31.8–32.1) 30.7 (30.1–31.3) 29.6 (29.3–30.0) 25.6 (25.3–25.8)
Mild (1–2) 55.7 (55.5–55.9) 57.6 (57.0–58.3) 55.6 (55.3–56.0) 58.4 (58.1–58.7)
Moderate/High (3+) 12.3 (12.2–12.5) 11.7 (11.3–12.1) 14.7 (14.5–15.0) 16.1 (15.8–16.3)
MAPLe scale
Stable (1) 38.3 (38.1–38.5) 13.1 (12.7–13.5) 12.0 (11.8–12.2) 1.6 (1.5–1.6)
Mild/Moderate (2–3) 53.1 (52.9–53.3) 46.9 (46.3–47.6) 40.4 (40.0–40.7) 16.3 (16.0–16.5)
High/Very high (4–5) 8.6 (8.5–8.7) 39.9 (39.3–40.6) 47.6 (47.3–48.0) 82.2 (81.9–82.4)
DRS
Yes (3+) 12.0 (11.8–12.1) 17.6 (17.1–18.1) 16.3 (16.1–16.6) 19.9 (19.7–20.1)
Aggressive Behaviour Scored
None (0) 98.6 (98.5–98.6) 94.5 (94.2–94.8) 90.2 (90.0–90.4) 73.3 (73.0–73.5)
Mild/Moderate (1) 1.2 (1.2–1.3) 4.0 (3.8–4.3) 6.7 (6.6–6.9) 16.7 (16.5–16.9)
Severe (2+) 0.2 (0.2–0.2) 1.5 (1.3–1.6) 3.1 (3.0–3.2) 10.0 (9.8–10.2)
Behavioural symptoms
Wandering 0.1 (0.0–0.1) 1.1 (1.0–1.3) 3.1 (3.0–3.2) 13.0 (12.8–13.2)
Verbally abusive 0.7 (0.6–0.7) 2.6 (2.4–2.8) 4.5 (4.4–4.6) 11.4 (11.2–11.6)
Physically abusive 0.0 (0.0–0.1) 0.5 (0.4–0.6) 1.2 (1.2–1.3) 3.9 (3.8–4.1)
Socially inappropriate/disruptive 0.2 (0.1–0.2) 1.3 (1.2–1.5) 2.2 (2.1–2.3) 6.9 (6.8–7.1)
Resists care 0.8 (0.8–0.9) 3.1 (2.9–3.3) 6.3 (6.2–6.5) 19.1 (18.8–19.3)
Mental Health
Any anxiety symptoms 10.3 (10.2–10.4) 15.6 (15.1–16.0) 14.8 (14.6–15.0) 22.6 (22.4–22.9)
Hallucinations or delusions 0.6 (0.6–0.7) 4.3 (4.0–4.6) 3.9 (3.8–4.0) 11.3 (11.1–11.4)
Diagnoses
Arthritis 51.6 (51.4–51.8) 42.0 (41.3–42.6) 49.9 (49.5–50.2) 43.6 (43.3–43.9)
Cancer (past 5 years) 25.6 (25.4–25.7) 9.8 (9.4–10.2) 12.1 (11.8–12.3) 8.5 (8.4–8.7)
Diabetes 25.9 (25.7–26.0) 17.9 (17.4–18.4) 30.5 (30.2–30.8) 19.9 (19.7–20.2)
Emphysema/COPD/asthma 19.4 (19.3–19.6) 12.4 (11.9–12.8) 16.9 (16.6–17.2) 11.6 (11.4–11.8)
Heart failure 13.9 (13.7–14.0) 7.3 (7.0–7.7) 16.1 (15.8–16.3) 10.2 (10.0–10.3)
Other CVDe 66.8 (66.6–67.0) 50.5 (49.9–51.2) 78.9 (78.6–79.2) 63.5 (63.2–63.8)
Health Issues
Fell < 90 days 27.1 (26.9–27.3) 45.3 (44.6–45.9) 37.1 (36.8–37.5) 35.1 (34.8–35.4)
Unsteady gait 52.5 (52.3–52.7) 74.7 (74.1–75.2) 71.6 (71.3–71.9) 59.0 (58.7–59.3)
Pressure ulcers 4.4 (4.3–4.5) 6.4 (6.1–6.7) 4.9 (4.7–5.0) 3.7 (3.6–3.8)
Swallowing problems 10.6 (10.4–10.7) 20.6 (20.1–21.2) 24.4 (24.1–24.7) 32.2 (31.9–32.5)
§ 1 ED visits < 90 days 21.0 (20.9–21.2) 19.5 (19.0–20.0) 20.9 (20.7–21.2) 17.5 (17.2–17.7)
§ 1 hospital admissions < 90 days 36.3 (36.1–36.5) 23.3 (22.8–23.9) 31.2 (30.9–31.5) 18.2 (18.0–18.5)
9+ medications 46.2 (46.0–46.4) 47.1 (46.4–47.7) 55.5 (55.1–55.8) 40.3 (40.0–40.6)
Continued on the following page
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Approximately half of dementia clients
used a dementia medication.
Compared with cognitively intact clients,
those with dementia, stroke or other
neurological conditions were more likely
to have received care from home health
care aides (61%–66% vs. 48%) and
homemaking services (42% vs. 31%) in
the previous seven days but were less
likely to have received care from a visiting
registered nurse (25%–28% vs. 40%).
Clients with dementia were also less likely
than all other groups to have received
physical therapy (7% vs. 13%–15%) or
TABLE 1B (continued)
Health characteristics among home care clients by diagnostic group, Ontario, Canada, 2003–2010
Characteristic Percent (95% confidence interval)a
Cognitively intactb
(n = 236 763)
Other neurological conditionsc
(n = 23 007)
Stroke
(n = 85 579)
Dementia
(n = 104 802)
Psychotropic drug use
Antipsychotic/neuroleptic 3.8 (3.7–3.8) 11.2 (10.8–11.6) 9.8 (9.6–10.0) 22.5 (22.2–22.8)
Anxiolytic 17.0 (16.8–17.1) 20.7 (20.2–21.2) 16.7 (16.5–17.0) 14.8 (14.6–15.1)
Antidepressant 18.1 (17.9–18.3) 30.1 (29.5–30.6) 27.1 (26.8–27.4) 28.4 (28.1–28.6)
Hypnotic 14.2 (14.1–14.4) 15.6 (15.1–16.1) 14.3 (14.1–14.5) 11.8 (11.6–12.0)
Any dementia medication 0.9 (0.9–1.0) 5.0 (4.7–5.3) 13.0 (12.8–13.2) 49.3 (49.0–49.6)
Abbreviations: CHESS, Changes in Health, End-stage Disease, and Signs and Symptoms; COPD, chronic obstructive pulmonary disease; CPS, Cognitive Performance Score; CVD, cardiovascular
disease; DRS, Depression Rating Scale; ED, emergency department; MAPLe, Method for Assigning Priority Levels; RAI-HC, Resident Assessment Instrument-Home Care.
a Except where otherwise indicated.
b Clients without any of the 11 selected neurological conditions and CPS of 0 or 1.
c Clients with § 1 of the other selected neurological conditions (excluding dementia and stroke).
d Summary scale of the following behaviours on the RAI-HC: verbally abusive, physically abusive, socially inappropriate/disruptive or resists care; higher scores indicate greater number and
frequency of behavioural issues.
e Includes the following cardiovascular conditions listed on the RAI-HC: coronary artery disease, hypertension, irregularly irregular pulse and/or peripheral vascular disease.
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occupational therapy (8% vs. 10%–16%)
in the previous week (data not shown;
details available on request).
Clients with dementia alone vs. dementia
with other neurological conditions
(Tables 2A & 2B)
The dementia cohort included 77 670
(74.1%) clients with dementia alone,
19 061 (18.2%) with co-existing stroke,
4480 (4.3%) with PD, 1182 (1.1%) with
both PD and stroke, and 763 (0.7%) with
TBI (Table 2A). There were 1646 (1.6%)
clients with dementia and some other
combination(s) with selected neurological
conditions that were rare and thus not
presented.
Dementia clients with co-existing PD (with
or without stroke) or TBI were generally
younger and more likely to be male
compared with the other two groups.
This age/sex distribution likely explains
the relatively higher proportion of married
clients (with an available co-residing
spousal caregiver) in the groups with
dementia and PD (with or without stroke).
Dementia clients with TBI were more
likely than the other groups to have
reported conflicts with others, and along
with those with PD (with or without
stroke), were more likely to have a
distressed caregiver. Dementia clients with
co-existing PD and stroke were more likely
to exhibit higher levels of cognitive impair-
ment and ADL dependence than the other
groups.
Moderate to high health instability was
slightly more common in dementia clients
with stroke (including stroke/PD) or TBI
(Table 2B). All groups showed similar
proportions at high/very high MAPLe
levels and with clinically important
depressive symptoms. Aggressive beha-
viours were less prevalent in dementia
clients with PD (with or without stroke)
and more common in those with co-
existing TBI. Anxiety symptoms were
slightly more common in dementia clients
with TBI, whereas hallucinations/delu-
sions were more prevalent in dementia
clients with PD.
Generally, various comorbid illnesses (e.g.
arthritis, diabetes, CVDs) were more com-
mon in dementia clients with co-existing
stroke and less common in those with co-
existing PD only. A recent fall, unsteady
gait and pressure ulcers were more com-
mon in dementia clients with co-existing
PD. Overall, compared with dementia-
only clients, all four groups with co-
existing neurological conditions showed
a higher prevalence of recent falls,
unsteady gait and problems with swallow-
ing (the latter were especially common in
those with dementia, PD and stroke). A
recent ED visit or hospitalization was also
more common in the four groups with a
co-existing neurological condition relative
to the dementia-only group. A recent
hospitalization was especially common
in dementia clients with stroke (including
stroke/PD) or TBI. The use of nine or
more medications was less common in
those with dementia alone or with TBI,
and more common in those with co-
existing stroke or PD (particularly stroke
with PD).
Dementia clients with PD (with or without
stroke) generally showed higher use of
antipsychotic/neuroleptic and antidepres-
sant medications compared with the other
groups. Clients with PD (no stroke) and
with dementia alone were more likely
than the other groups to be using a
cholinesterase inhibitor and/or meman-
tine, whereas those with TBI or stroke (no
PD) showed the lowest use.
Discussion
Findings from this population-based study
of home care clients in Ontario highlight
the substantial psychosocial, functional
and mental health needs of people with
dementia who live in the community. Our
work expands on previous literature by
providing a recent and comprehensive
profile of the key domains relevant to the
care, quality of life and health outcomes of
this growing population. As a further
contribution, we provide estimates of the
prevalence of common co-existing neuro-
logical conditions and the associated
complexity of health and care planning
needs imposed by this comorbidity.
Clients with dementia vs. stroke, other
neurological conditions and cognitively
intact controls
Approximately 22% of Ontario long-stay
home care clients (n = 104 802) had been
FIGURE 2
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Vol 34, No 2-3, July 2014 – Chronic Diseases and Injuries in Canada $138
TABLE 2A
Sociodemographic, psychosocial and functional characteristics among home care clients with dementia (by co-existing neurological
condition), Ontario, Canada, 2003–2010
Characteristic Percent (95% confidence interval)a
Dementia onlyb Dementia and strokec Dementia and PDc Dementia, PD and stroked Dementia and TBIc
(n = 77 670) (n = 19 061) (n = 4480) (n = 1182) (n = 763)
Sociodemographic
Mean age (SD), years 83.5 (7.5) 83.3 (7.3) 80.6 (6.9) 81.7 (6.6) 80.1 (9.6)
85+ 45.4 (45.1–45.8) 43.2 (42.5–43.9) 26.5 (25.2–27.8) 30.1 (27.5–32.7) 35.0 (31.6–38.4)
Sex
Female 67.2 (66.9–67.6) 57.2 (56.4–57.9) 41.4 (40.0–42.8) 39.5 (36.7–42.3) 51.9 (48.3–55.5)
Married
Male 63.0 (62.4–63.6) 68.6 (67.6–69.6) 77.6 (76.0–79.2) 78.0 (75.0–81.1) 61.9 (56.9–66.8)
Female 26.4 (26.0–26.7) 26.6 (25.8–27.5) 38.7 (36.5–40.9) 30.6 (26.4–34.8) 29.8 (25.3–34.3)
Made economic trade-offs 0.9 (0.8–1.0) 1.3 (1.1–1.4) 1.3 (0.9–1.6) 1.1 (0.5–1.7) 2.1 (1.1–3.1)
Psychosocial
Co-resides with primary caregiver
No 45.5 (45.1–45.8) 37.1 (36.4–37.8) 29.5 (28.2–30.9) 25.5 (23.0–28.0) 43.6 (40.0–47.1)
Yes 53.4 (53.0–53.7) 62.1 (61.4–62.8) 69.8 (68.4–71.1) 74.2 (71.7–76.7) 54.7 (51.2–58.3)
No such helper 1.1 (1.1–1.2) 0.8 (0.7–1.0) 0.7 (0.5–1.0) 0.3 (0.0–0.7) 1.7 (0.8–2.6)
Primary caregiver
Child or child-in-law 55.4 (55.1–55.8) 52.4 (51.7–53.2) 38.0 (36.5–39.4) 42.6 (39.8–45.5) 46.8 (43.2–50.3)
Spouse 31.2 (30.8–31.5) 37.6 (36.9–38.3) 53.9 (52.4–55.3) 51.4 (48.6–54.3) 37.4 (33.9–40.8)
Other relative 8.1 (7.9–8.3) 6.0 (5.6–6.3) 4.8 (4.2–5.4) 3.7 (2.6–4.8) 9.6 (7.5–11.7)
Friend/neighbour 4.1 (4.0–4.3) 3.2 (2.9–3.4) 2.6 (2.1–3.1) 1.9 (1.1–2.6) 4.5 (3.0–5.9)
Conflicts with others 17.4 (17.2–17.7) 17.1 (16.6–17.6) 14.5 (13.5–15.5) 14.0 (12.0–15.9) 21.7 (18.7–24.6)
Caregiver distressed 34.4 (34.1–34.8) 35.2 (34.5–35.8) 39.3 (37.9–40.7) 39.5 (36.7–42.3) 40.4 (36.9–43.9)
Functional
CPS score
Intact (0–1) 7.5 (7.3–7.7) 7.0 (6.7–7.4) 8.0 (7.2–8.8) 5.8 (4.5–7.2) 6.7 (4.9–8.5)
Mild impairment (2) 45.3 (44.9–45.6) 43.5 (42.8–44.2) 42.7 (41.3–44.2) 37.3 (34.5–40.1) 40.4 (36.9–43.9)
Moderate impairment (3–4) 29.3 (29.0–29.6) 29.5 (28.9–30.2) 27.5 (26.1–28.8) 29.9 (27.3–32.5) 33.0 (29.7–36.4)
Severe impairment (5–6) 18.0 (17.7–18.2) 20.0 (19.4–20.6) 21.8 (20.6–23.0) 27.0 (24.5–29.5) 19.9 (17.1–22.8)
ADL score
Independent (0) 39.9 (39.6–40.3) 31.8 (31.1–32.4) 21.0 (19.8–22.2) 17.5 (15.3–19.7) 36.8 (33.4–40.3)
Supervision/Limited (1–2) 38.2 (37.9–38.6) 37.0 (36.3–37.7) 37.2 (35.7–38.6) 34.1 (31.4–36.8) 37.6 (34.2–41.1)
Extensive (3–4) 17.1 (16.8–17.3) 21.8 (21.2–22.4) 30.8 (29.5–32.2) 30.2 (27.6–32.8) 20.1 (17.2–22.9)
Dependence (5–6) 4.8 (4.6–4.9) 9.4 (9.0–9.8) 11.1 (10.1–12.0) 18.2 (16.0–20.4) 5.5 (3.9–7.1)
IADL scoree
0 0.8 (0.7–0.8) 0.4 (0.3–0.5) 0.2 (0.1–0.4) 0.3 (0.0–0.5) 0.7 (0.1–1.2)
1–2 4.8 (4.6–4.9) 3.3 (3.1–3.6) 2.5 (2.1–3.0) 1.4 (0.8–2.1) 5.5 (3.9–7.1)
3–4 94.5 (94.3–94.6) 96.2 (96.0–96.5) 97.2 (96.8–97.7) 98.3 (97.6–99.0) 93.8 (92.1–95.5)
Abbreviations: ADL, Activities of Daily Living; CPS, Cognitive Performance Score; IADL, Instrumental Activities of Daily Living; PD, Parkinson disease/Parkinsonism; SD, standard deviation;
TBI, traumatic brain injury.
a Except where otherwise indicated.
b Excludes the other 10 selected neurological conditions.
c Excludes the other 9 selected neurological conditions.
d Excludes the other 8 selected neurological conditions.
e Summary scale of the following IADLs on the RAI-HC: meal preparation, managing finances, managing medications and transportation; represents # of activities where client experiencing
some/greater difficulty performing on own.
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TABLE 2B
Health characteristics among home care clients with dementia (by co-existing neurological condition), Ontario, Canada, 2003–2010
Characteristic Percent (95% confidence interval)a
Dementia onlyb Dementia and strokec Dementia and PDc Dementia, PD and stroked Dementia and TBIc
(n = 77 670) (n = 19 061) (n = 4480) (n = 1182) (n = 763)
Health instability (CHESS)
None (0) 25.8 (25.5–26.1) 25.1 (24.5–25.7) 23.1 (21.9–24.4) 22.3 (19.9–24.6) 25.0 (22.0–28.1)
Mild (1–2) 58.7 (58.3–59.0) 56.8 (56.1–57.5) 60.8 (59.3–62.2) 58.5 (55.6–61.3) 54.1 (50.6–57.7)
Moderate/High (3+) 15.5 (15.2–15.7) 18.1 (17.5–18.6) 16.1 (15.0–17.2) 19.3 (17.0–21.5) 20.8 (18.0–23.7)
MAPLe Scale
Stable (1) 1.7 (1.6–1.8) 1.1 (0.9–1.2) 0.8 (0.6–1.1) 0.7 (0.2–1.1) 1.6 (0.7–2.5)
Mild/Moderate (2–3) 15.9 (15.6–16.2) 17.2 (16.7–17.8) 19.1 (17.9–20.2) 16.8 (14.6–18.9) 12.2 (9.9–14.5)
High/Very high (4–5) 82.4 (82.1–82.6) 81.7 (81.1–82.2) 80.1 (78.9–81.3) 82.6 (80.4–84.7) 86.2 (83.8–88.7)
DRS
Yes (3+) 19.7 (19.4–19.9) 20.0 (19.4–20.6) 21.6 (20.4–22.8) 22.8 (20.4–25.2) 24.9 (21.9–28.0)
Aggressive Behaviour Scoree
None (0) 72.5 (72.2–72.8) 74.7 (74.1–75.4) 78.8 (77.6–80.0) 79.1 (76.8–81.4) 68.3 (65.0–71.6)
Mild/moderate (1) 17.1 (16.9–17.4) 16.1 (15.5–16.6) 14.0 (13.0–15.0) 13.5 (11.6–15.5) 17.0 (14.3–19.6)
Severe (2+) 10.4 (10.2–10.6) 9.2 (8.8–9.6) 7.3 (6.5–8.0) 7.4 (5.9–8.9) 14.7 (12.2–17.2)
Behavioural symptoms
Wandering 13.8 (13.6–14.1) 10.4 (10.0–10.8) 10.5 (9.6–11.4) 9.0 (7.3–10.6) 17.6 (14.9–20.3)
Verbally abusive 11.5 (11.3–11.8) 11.3 (10.8–11.7) 8.4 (7.6–9.2) 8.9 (7.3–10.5) 16.1 (13.5–18.8)
Physically abusive 4.0 (3.8–4.1) 3.8 (3.5–4.0) 3.5 (2.9–4.0) 3.8 (2.7–4.9) 6.6 (4.8–8.3)
Socially inappropriate/disruptive 7.1 (7.0–7.3) 6.4 (6.1–6.8) 5.1 (4.4–5.7) 5.8 (4.4–7.1) 9.7 (7.6–11.8)
Resists care 19.9 (19.6–20.2) 17.2 (16.6–17.7) 14.7 (13.6–15.7) 13.6 (11.7–15.6) 22.5 (19.5–25.4)
Mental health
Any anxiety symptoms 22.9 (22.6–23.2) 21.5 (20.9–22.0) 22.9 (21.7–24.2) 21.1 (18.7–23.4) 26.8 (23.6–29.9)
Hallucinations or delusions 11.0 (10.8–11.2) 9.9 (9.5–10.3) 20.0 (18.9–21.2) 16.6 (14.5–18.7) 14.3 (11.8–16.8)
Diagnoses
Arthritis 43.1 (42.7–43.4) 46.7 (46.0–47.4) 38.9 (37.4–40.3) 48.6 (45.7–51.4) 45.1 (41.5–48.6)
Cancer (past 5 years) 8.3 (8.1–8.5) 9.5 (9.1–10.0) 8.0 (7.2–8.8) 8.6 (7.0–10.2) 8.1 (6.2–10.1)
Diabetes 18.6 (18.3–18.9) 25.7 (25.0–26.3) 17.0 (15.9–18.1) 24.1 (21.7–26.6) 21.5 (18.6–24.4)
Emphysema/COPD/asthma 11.2 (11.0–11.4) 13.5 (13.0–14.0) 9.2 (8.3–10.0) 11.5 (9.7–13.3) 13.5 (11.1–15.9)
Heart failure 9.4 (9.2–9.6) 13.9 (13.5–14.4) 6.7 (6.0–7.4) 12.2 (10.3–14.1) 11.3 (9.0–13.5)
Other CVDf 61.1 (60.8–61.4) 75.9 (75.3–76.5) 51.1 (49.7–52.6) 71.7 (69.2–74.3) 62.4 (58.9–65.8)
Health issues
Fell < 90 days 32.8 (32.4–33.1) 38.4 (37.7–39.1) 52.2 (50.7–53.6) 48.6 (45.8–51.5) 47.7 (44.2–51.3)
Unsteady gait 54.6 (54.2–54.9) 69.1 (68.4–69.7) 81.0 (79.8–82.1) 82.2 (80.1–84.4) 68.4 (65.1–71.7)
Pressure ulcers 3.2 (3.0–3.3) 4.7 (4.4–5.0) 6.6 (5.9–7.3) 8.3 (6.7–9.9) 3.1 (1.9–4.4)
Swallowing problems 29.9 (29.6–30.3) 38.4 (37.7–39.1) 37.5 (36.1–38.9) 46.6 (43.8–49.5) 35.4 (32.0–38.8)
§ 1 ED visits < 90 days 16.6 (16.3–16.8) 19.9 (19.4–20.5) 19.0 (17.9–20.2) 19.5 (17.3–21.8) 23.3 (20.3–26.3)
§ 1 hospital admissions < 90 days 16.4 (16.1–16.6) 24.6 (23.9–25.2) 18.7 (17.5–19.8) 24.4 (21.9–26.8) 24.8 (21.7–27.8)
9+ Medications 37.1 (36.8–37.5) 50.1 (49.3–50.8) 47.1 (45.6–48.6) 56.7 (53.9–59.5) 38.5 (35.1–42.0)
Psychotropic drug use
Antipsychotic/neuroleptic 22.4 (22.1–22.7) 21.0 (20.4–21.6) 27.0 (25.7–28.3) 25.8 (23.3–28.3) 25.0 (22.0–28.1)
Anxiolytic 14.5 (14.2–14.7) 15.4 (14.9–15.9) 16.9 (15.8–17.9) 16.6 (14.5–18.7) 16.3 (13.6–18.9)
Antidepressant 27.2 (26.9–27.5) 31.1 (30.5–31.8) 33.2 (31.9–34.6) 34.6 (31.9–37.3) 30.0 (26.8–33.3)
Continued on the following page
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diagnosed as having dementia. A common
profile was that of an older (>75 years)
widowed woman supported by a child (or
child-in-law) as her primary caregiver.
However, in about one-third of dementia
clients, the primary caregiver was a spouse
who was likely of the same age or older and
likely soon facing challenges to his/her own
health and social well-being. Approximately
43% of dementia clients (and 50% of those
with cognitive impairment but no diagnosis)
did not co-reside with their primary care-
giver. The lack of a close or well-informed
advocate available to monitor and commu-
nicate their needs in a timely manner may
lead to an increased risk of fragmented or
sub-optimal care and more rapid disease
progression.40,41
Almost half of dementia clients had
moderate to severe cognitive impairment
(CPS score 3+) and almost all experienced
some or great difficulty with multiple
IADLs. As informal and formal care costs
increase with dementia severity,3,6,42 this
finding has important implications for
family caregivers, health care providers
and policy makers. Consistent with their
level of cognitive impairment, dementia
clients showed a significantly higher pre-
valence of aggression, anxiety, wandering
and hallucinations/delusions than other
diagnostic groups. They were also more
likely to exhibit clinically important
depressive symptoms. In their examina-
tion of 2005 Canadian Community Health
Survey participants aged 55 years and
over, Nabalamba and Patten43 also
observed higher levels of mood (19.5%)
and anxiety (16.3%) disorders in people
with dementia. The clustering of cogni-
tive, behavioural and psychiatric issues
evident in dementia clients helps to
explain the greater likelihood of caregiver
distress17 (approximately 35% of family
caregivers in our study) as well as clients’
increased risk of institutionalization17,44
and higher care costs.42,45 Specifically,
82% of clients with dementia displayed
high to very high MAPLe scores indicating
an imminent risk for transition to a higher
level of care.
Clients with dementia (and those with
other neurological conditions) showed a
lower prevalence of several chronic con-
ditions (including cardiovascular diseases,
arthritis, diabetes, COPD and cancer) and
lower levels of recent health service use
(e.g. emergency room visits or hospitali-
zations in the previous 3 months and use
of 9+ medications). While earlier research
reported people with dementia (particu-
larly those with Alzheimer disease) as
being relatively healthier,46,47 recent find-
ings have been inconsistent.45,48 The one
exception is the lower prevalence of
cancer consistently noted for those with
dementia and other neurological condi-
tions.49 These inconsistencies likely reflect
variations across investigations in study
design and samples (e.g. sociodemo-
graphic characteristics, dementia severity
and sub-types examined) and in the
diagnostic and clinical health measures
employed. Several studies have reported
higher rates of comorbid health condi-
tions, medication and health service use
for those with vascular dementia (as
compared with Alzheimer disease).46,48
Our findings for dementia clients with
co-existing stroke (Table 2B) are consis-
tent with these reports. For some condi-
tions, a lower prevalence may be the
consequence of poorer detection and
under-diagnosis in people with a dementia
disorder.48 Factors underlying this poorer
recognition may include the atypical pre-
sentation of some conditions and the
under-reporting of symptoms in patients
with dementia as well as the stigma
associated with the diagnosis of dementia.
Additional efforts to investigate this pos-
sibility and potential strategies for
improved detection of existing comorbid-
ities in patients with dementia are war-
ranted.50 It should also be noted that
dementia clients were significantly more
likely to experience swallowing difficulties
and to use antipsychotic/neuroleptic med-
ications, both of which represent risk
factors for decline and hospitalization.45,51
Clients with dementia alone vs. dementia
with other neurological conditions
Approximately one in four dementia cli-
ents had a co-existing neurological condi-
TABLE 2B (continued)
Health characteristics among home care clients with dementia (by co-existing neurological condition), Ontario, Canada, 2003–2010
Characteristic Percent (95% confidence interval)a
Dementia onlyb Dementia and strokec Dementia and PDc Dementia, PD and stroked Dementia and TBIc
(n = 77 670) (n = 19 061) (n = 4480) (n = 1182) (n = 763)
Hypnotic 11.3 (11.1–11.5) 13.0 (12.5–13.5) 13.0 (12.1–14.0) 13.2 (11.3–15.1) 16.1 (13.5–18.7)
Any dementia medication 51.4 (51.0–51.7) 41.7 (41.0–42.4) 53.9 (52.5–55.4) 46.4 (43.5–49.2) 38.8 (35.3–42.3)
Abbreviations: CHESS, Changes in Health, End-stage Disease, and Signs and Symptoms; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; DRS, Depression Rating
Scale; ED, emergency department; MAPLe, Method for Assigning Priority Levels; PD, Parkinson disease/Parkinsonism; RAI-HC, Resident Assessment Instrument-Home Care; SD, standard
deviation; TBI, traumatic brain injury.
a Except where otherwise indicated.
b Excludes the other 10 selected neurological conditions.
c Excludes the other 9 selected neurological conditions.
d Excludes the other 8 selected neurological conditions.
e Summary scale of the following behaviours on the RAI-HC: verbally abusive, physically abusive, socially inappropriate/disruptive or resists care; higher scores indicate greater number and
frequency of behavioural issues.
f Includes the following cardiovascular conditions listed on the RAI-HC: coronary artery disease, hypertension, irregularly irregular pulse or peripheral vascular disease.
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tion (specific to our targeted conditions),
most often stroke and then PD and TBI.
Others have documented the relatively
common co-occurrence of dementia in
people with stroke or with PD.20,52
Clients documented as having all three
conditions (dementia, PD and stroke)
showed the greatest burden in terms of
more severe cognitive and ADL impair-
ment. Compared with dementia-only cli-
ents, all four groups with co-existing
neurological conditions showed a higher
prevalence of recent falls, unsteady gait,
swallowing problems (with the latter
present in almost 50% of those with
dementia, PD and stroke) and recent
health service use.
Dementia clients with selected co-existing
neurological conditions were also found
to exhibit unique sociodemographic and
health profiles. Those with dementia and
PD were more likely to be younger and male
and consequently more likely to co-reside
with a spousal caregiver. In dementia
clients with PD or with TBI, approximately
40% were noted to have a distressed
caregiver (compared with about 35% for
the other groups). Yet the underlying factors
possibly contributing to caregiver burden
varied in these groups. For example,
dementia clients with TBI were more
likely than other groups to experience
conflicts with others, aggressive beha-
viours, wandering and recent worsening
of mood and/or behaviours. Conversely,
those with PD were less likely to have
behavioural issues or conflicts but more
likely to exhibit hallucinations and/or
delusions.
There was evidence of greater health
instability (e.g. higher CHESS scores and
recent hospital use) in dementia clients
with co-existing stroke or TBI. Further,
those with dementia and co-existing
stroke showed a higher prevalence of
common comorbid health conditions
(including cardiovascular illness, diabetes
and arthritis) and polypharmacy (9+ med-
ications). Although less likely than others
to exhibit these comorbid health condi-
tions, dementia clients with PD were more
likely to have a recent fall, unsteady gait
and pressure ulcers. The variation in
cholinesterase inhibitor and/or meman-
tine use observed in dementia clients with
co-existing neurological conditions is intrigu-
ing and has been more fully examined in a
separate publication.53
The unique care needs observed for
particular dementia sub-groups illustrate
the importance of tailored and co-ordi-
nated home care services.13 For example,
further educational resources and beha-
vioural management strategies may be a
priority for dementia clients with TBI (and
their caregivers) whereas dementia clients
with PD may have a greater need for fall
prevention strategies and rehabilitation
services and dementia clients with co-
existing stroke will need enhanced chronic
disease management.
Important strengths of our study include
the examination of a large population-
based sample of older home care clients
(allowing for greater precision in estim-
ates, stratification by diagnostic sub-
groups and generalizability) and the com-
plete and comprehensive nature of the
RAI-HC assessment data. However, some
limitations should be noted. Despite evi-
dence supporting the validity of diagnostic
data on the RAI-HC (including demen-
tia),37-39 further validation work is
required. In addition, the diagnostic and
cognitive data captured on the RAI-HC
does not permit a differentiation of
dementia sub-type (an important predictor
of care needs and service use).
Approximately 12.1% of clients (without
a recorded neurological diagnosis) had
moderate to significant cognitive impair-
ment, and a proportion in this group
(particularly those with a CPS score of
4+) are likely to have had a dementia
disorder. The potential for diagnostic
misclassification may have resulted in a
reduced ability to detect relevant differ-
ences in client characteristics across some
of our comparison groups. The cross-
sectional nature of our data and the
absence of prospective data on actual
health system and home care use also
limits our ability to comment on the
differential burden and unmet care needs
associated with selected co-existing neu-
rological conditions in dementia clients.
Conclusions
Our findings suggest that a significant
proportion of clients currently living with
dementia in the community may be close
to the tipping point in terms of their
continued ability to remain in their own
homes. These data support the argument
that more flexible and enhanced commu-
nity-based and caregiver assistance pro-
grams may be needed to ensure continued
client and caregiver well-being and quality
of care.13,54 Of critical importance for all
dementia clients (given the burden of
mood and anxiety disorders) is the
immediate need for improved, co-ordi-
nated and integrated psychiatric and men-
tal health services (with intensive case
management).43 Care providers (including
case managers, primary care physicians
and family caregivers) may face numerous
structural barriers in obtaining access to
appropriate mental health specialists and
services,55 leading to an increased like-
lihood for delayed or inappropriate treat-
ment and poor outcomes for community-
dwelling seniors with dementia. Further
work detailing the extent and conse-
quences of unmet needs associated with
co-existing mental health and neurological
conditions in dementia is clearly war-
ranted.
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